M
Molecular Data Inc
NASDAQ:MKD
Molecular Data Inc
NASDAQ:MKD
Price:
0.0022 USD
10%
Market Closed
Updated:
May 4, 2024
Molecular Data Inc
Cost of Revenue
|
Molecular Data Inc
Cost of Revenue Peer Comparison
Comparables:
BABA
PDD
6618
3690
9618
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
M
|
Molecular Data Inc
NASDAQ:MKD
|
Cost of Revenue
-¥7.6B
|
CAGR 3-Years
-22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Cost of Revenue
-¥577B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
-47%
|
|
|
Pinduoduo Inc
NASDAQ:PDD
|
Cost of Revenue
-¥91.7B
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-99%
|
CAGR 10-Years
N/A
|
|
|
JD Health International Inc
HKEX:6618
|
Cost of Revenue
-¥36.8B
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-55%
|
CAGR 10-Years
N/A
|
|
|
Meituan
HKEX:3690
|
Cost of Revenue
-¥179.6B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
|
JD.Com Inc
HKEX:9618
|
Cost of Revenue
-¥925B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-31%
|
See Also
What is Molecular Data Inc's Cost of Revenue?
Cost of Revenue
-7.6B
CNY
-7.6B
CNY
Based on the financial report for Dec 31, 2020, Molecular Data Inc's Cost of Revenue amounts to -7.6B CNY.
What is Molecular Data Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-22%
-22%
Over the last year, the Cost of Revenue growth was 42%. The average annual Cost of Revenue growth rates for Molecular Data Inc have been -22% over the past three years .
You don't have any saved screeners yet
